603 related articles for article (PubMed ID: 27501772)
21. Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization.
Tian Y; Zeng T; Tan L; Wu Y; Yu J; Huang J; Pei Z
J Clin Lab Anal; 2019 Jul; 33(6):e22908. PubMed ID: 31106488
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
23. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
24. Decreased concentration of IL-35 in plasma of patients with asthma and COPD.
Chen C; Deng Y; Chen H; Wu X; Cheng S; Xu Y; Xiong W; Xie J
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):211-7. PubMed ID: 25268338
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review.
Nielsen M; Bårnes CB; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():1443-54. PubMed ID: 26251584
[TBL] [Abstract][Full Text] [Related]
26. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
27. Serum IL-8 and VEGFA are Two Promising Diagnostic Biomarkers of Asthma-COPD Overlap Syndrome.
Ding Q; Sun S; Zhang Y; Tang P; Lv C; Ma H; Yu Y; Xu S; Deng Z
Int J Chron Obstruct Pulmon Dis; 2020; 15():357-365. PubMed ID: 32103934
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease, asthma-COPD overlap syndrome and bronchial asthma.
Kodama Y; Kishimoto Y; Muramatsu Y; Tatebe J; Yamamoto Y; Hirota N; Itoigawa Y; Atsuta R; Koike K; Sato T; Aizawa K; Takahashi K; Morita T; Homma S; Seyama K; Ishigami A
Clin Respir J; 2017 Nov; 11(6):915-924. PubMed ID: 26667049
[TBL] [Abstract][Full Text] [Related]
29. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach.
Inoue H; Nagase T; Morita S; Yoshida A; Jinnai T; Ichinose M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1803-1810. PubMed ID: 28694693
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of changes in serum inflammatory factors in patients with chronic obstructive pulmonary disease and pulmonary infection.
Zhou J; Jin F; Wu F
J Int Med Res; 2021 May; 49(5):3000605211013275. PubMed ID: 34018839
[TBL] [Abstract][Full Text] [Related]
33. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
[TBL] [Abstract][Full Text] [Related]
35. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
Li L; Liu Y; Li J; Gao JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
[No Abstract] [Full Text] [Related]
36. [Interleukin-38 expression and clinical significance in serum of patients with chronic obstructive pulmonary disease].
Zhu YQ; Ma SP; Li B; Zheng CY; Ma J
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(10):759-762. PubMed ID: 29562401
[No Abstract] [Full Text] [Related]
37. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.
Lacedonia D; Palladino GP; Foschino-Barbaro MP; Scioscia G; Carpagnano GE
Int J Chron Obstruct Pulmon Dis; 2017; 12():1811-1817. PubMed ID: 28694694
[TBL] [Abstract][Full Text] [Related]
38. Milkvetch root improves immune function in patients with acute exacerbation of COPD.
Jiang D; Wang X; Su Q; Jiang S; Yuan F; Zhang C; Gong F; Dong Q; Shi J; Chen B
Biomed Mater Eng; 2015; 26 Suppl 1():S2113-21. PubMed ID: 26405990
[TBL] [Abstract][Full Text] [Related]
39. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD.
Chen BB; Li ZH; Gao S
Medicine (Baltimore); 2018 Feb; 97(7):e9820. PubMed ID: 29443743
[TBL] [Abstract][Full Text] [Related]
40. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
